Buie, M. J. et al. Global Hospitalization trends for crohn’s disease and ulcerative colitis in the 21st Century: A systematic review with temporal analyses. Clin. Gastroenterol. Hepatol. Offic. Clin. Pract. J. Am. Gastroenterol. Assoc. https://doi.org/10.1016/j.cgh.2022.06.030 (2022).Article
Google Scholar
Chen, X. et al. Evolving trends and burden of inflammatory bowel disease in Asia, 1990–2019: A comprehensive analysis based on the global burden of disease study. J. Epidemiol. Glob. Health https://doi.org/10.1007/s44197-023-00145-w (2023).Article
PubMed
PubMed Central
Google Scholar
Flynn, S. & Eisenstein, S. Inflammatory bowel disease presentation and diagnosis. Surg. Clin. North Am. 99, 1051–1062. https://doi.org/10.1016/j.suc.2019.08.001 (2019).Article
PubMed
Google Scholar
Long, X. Q. et al. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease. World J. Gastroenterol. 29, 4252–4270. https://doi.org/10.3748/wjg.v29.i27.4252 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Banerjee, R., Pal, P., Mak, J. W. Y. & Ng, S. C. Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol. Hepatol. 5, 1076–1088. https://doi.org/10.1016/s2468-1253(20)30299-5 (2020).Article
PubMed
Google Scholar
Seishima, R. et al. Effect of biologics on the risk of advanced-stage inflammatory bowel disease-associated intestinal cancer: A nationwide study. Am. J. Gastroenterol. 118, 1248–1255. https://doi.org/10.14309/ajg.0000000000002149 (2023).Article
CAS
PubMed
Google Scholar
Baumgart, D. C. & Le Berre, C. Newer biologic and small-molecule therapies for inflammatory bowel disease. N. Engl. J. Med. 385, 1302–1315. https://doi.org/10.1056/NEJMra1907607 (2021).Article
CAS
PubMed
Google Scholar
Ahmed, W. et al. Dual biologic or small molecule therapy for treatment of inflammatory bowel disease: A systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. Offic. Clin. Pract. J. Am. Gastroenterol. Assoc. 20, e361–e379. https://doi.org/10.1016/j.cgh.2021.03.034 (2022).Article
CAS
Google Scholar
Lee, M. & Chang, E. B. Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology 160, 524–537. https://doi.org/10.1053/j.gastro.2020.09.056 (2021).Article
CAS
PubMed
Google Scholar
Guan, Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J. Immunol. Res. 2019, 7247238. https://doi.org/10.1155/2019/7247238 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Scoville, E. A. et al. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabol. Off. J. Metabol. Soc. 14, 17. https://doi.org/10.1007/s11306-017-1311-y (2018).Article
CAS
Google Scholar
Di’Narzo, A. F. et al. Integrative analysis of the inflammatory bowel disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets. Gastroenterology 162, 828-843.e811. https://doi.org/10.1053/j.gastro.2021.11.015 (2022).Article
CAS
PubMed
Google Scholar
Kettunen, J. et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat. Commun. 7, 11122. https://doi.org/10.1038/ncomms11122 (2016).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Emdin, C. A., Khera, A. V. & Kathiresan, S. Mendelian randomization. Jama 318, 1925–1926. https://doi.org/10.1001/jama.2017.17219 (2017).Article
PubMed
Google Scholar
Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. Jama 326, 1614–1621. https://doi.org/10.1001/jama.2021.18236 (2021).Article
PubMed
Google Scholar
Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Natu. Genet. 46, 543–550. https://doi.org/10.1038/ng.2982 (2014).Article
CAS
Google Scholar
Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508–518. https://doi.org/10.1038/s41586-022-05473-8 (2023).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Guo, M. N. et al. Human blood metabolites and lacunar stroke: A Mendelian randomization study. Int. J. Stroke Offic. J. Int. Stroke Soc. 18, 109–116. https://doi.org/10.1177/17474930221140792 (2023).Article
Google Scholar
Yu, X. H., Cao, R. R., Yang, Y. Q. & Lei, S. F. Identification of causal metabolites related to multiple autoimmune diseases. Human Mol. Genet. 31, 604–613. https://doi.org/10.1093/hmg/ddab273 (2022).Article
CAS
Google Scholar
Cai, J. et al. Genetic liability for prescription opioid use and risk of cardiovascular diseases: A multivariable Mendelian randomization study. Addiction 117, 1382–1391. https://doi.org/10.1111/add.15767 (2022).Article
PubMed
Google Scholar
Palmer, T. M. et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat. Methods Med. Res. 21, 223–242. https://doi.org/10.1177/0962280210394459 (2012).Article
MathSciNet
PubMed
PubMed Central
Google Scholar
Gill, D., Efstathiadou, A., Cawood, K., Tzoulaki, I. & Dehghan, A. Education protects against coronary heart disease and stroke independently of cognitive function: Evidence from Mendelian randomization. Int. J. Epidemiol. 48, 1468–1477. https://doi.org/10.1093/ije/dyz200 (2019).Article
PubMed
PubMed Central
Google Scholar
Bisgaard, T. H., Allin, K. H., Keefer, L., Ananthakrishnan, A. N. & Jess, T. Depression and anxiety in inflammatory bowel disease: Epidemiology, mechanisms and treatment. Nat. Rev. Gastroenterol. Hepatol. 19, 717–726. https://doi.org/10.1038/s41575-022-00634-6 (2022).Article
PubMed
Google Scholar
Timmer, A., Sutherland, L. R. & Martin, F. Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. The Canadian Mesalamine for Remission of Crohn’s Disease Study Group. Gastroenterology 114, 1143–1150. https://doi.org/10.1016/s0016-5085(98)70419-6 (1998).Article
CAS
PubMed
Google Scholar
Ananthakrishnan, A. N. et al. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: An International Organization for Study of Inflammatory Bowel Diseases consensus. Lancet Gastroenterol. Hepatol. 7, 666–678. https://doi.org/10.1016/s2468-1253(22)00021-8 (2022).Article
PubMed
Google Scholar
Barberio, B. et al. Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: A systematic review and meta-analysis. Gastroenterology 161, 1865–1877. https://doi.org/10.1053/j.gastro.2021.08.032 (2021).Article
CAS
PubMed
Google Scholar
Burgess, S., Scott, R. A., Timpson, N. J., Davey Smith, G. & Thompson, S. G. Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543–552. https://doi.org/10.1007/s10654-015-0011-z (2015).Article
PubMed
PubMed Central
Google Scholar
Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658–665. https://doi.org/10.1002/gepi.21758 (2013).Article
PubMed
PubMed Central
Google Scholar
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525. https://doi.org/10.1093/ije/dyv080 (2015).Article
PubMed
PubMed Central
Google Scholar
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314. https://doi.org/10.1002/gepi.21965 (2016).Article
PubMed
PubMed Central
Google Scholar
Hartwig, F. P., Davey Smith, G. & Bowden, J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol. 46, 1985–1998. https://doi.org/10.1093/ije/dyx102 (2017).Article
PubMed
PubMed Central
Google Scholar
Greco, M. F., Minelli, C., Sheehan, N. A. & Thompson, J. R. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat. Med. 34, 2926–2940. https://doi.org/10.1002/sim.6522 (2015).Article
MathSciNet
Google Scholar
Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: The role of the I2 statistic. Int. J. Epidemiol. 45, 1961–1974. https://doi.org/10.1093/ije/dyw220 (2016).Article
PubMed
PubMed Central
Google Scholar
Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693–698. https://doi.org/10.1038/s41588-018-0099-7 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Burgess, S. & Thompson, S. G. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 32, 377–389. https://doi.org/10.1007/s10654-017-0255-x (2017).Article
PubMed
PubMed Central
Google Scholar
Glickman, M. E., Rao, S. R. & Schultz, M. R. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J. Clin. Epidemiol 67, 850–857. https://doi.org/10.1016/j.jclinepi.2014.03.012 (2014).Article
PubMed
Google Scholar
Li, P. et al. Association between gut microbiota and preeclampsia-eclampsia: A two-sample Mendelian randomization study. BMC Med. 20, 443. https://doi.org/10.1186/s12916-022-02657-x (2022).Article
PubMed
PubMed Central
Google Scholar
O’Connor, L. J. & Price, A. L. Distinguishing genetic correlation from causation across 52 diseases and complex traits. Nat. Genet. 50, 1728–1734. https://doi.org/10.1038/s41588-018-0255-0 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081. https://doi.org/10.1371/journal.pgen.1007081 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Pang, Z. et al. MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388-w396. https://doi.org/10.1093/nar/gkab382 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Gu, Y. et al. Causality of genetically determined metabolites and metabolic pathways on osteoarthritis: A two-sample mendelian randomization study. J. Transl. Med. 21, 357. https://doi.org/10.1186/s12967-023-04165-9 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Yu, X. H. et al. Systematic evaluation for the causal effects of blood metabolites on osteoporosis: Genetic risk score and Mendelian randomization. Front. Public Health 10, 905178. https://doi.org/10.3389/fpubh.2022.905178 (2022).Article
PubMed
PubMed Central
Google Scholar
Johnson, C. H., Ivanisevic, J. & Siuzdak, G. Metabolomics: Beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17, 451–459. https://doi.org/10.1038/nrm.2016.25 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, J. et al. Metabolomics window into the diagnosis and treatment of inflammatory bowel disease in recent 5 years. Int. Immunopharmacol. 113, 109472. https://doi.org/10.1016/j.intimp.2022.109472 (2022).Article
CAS
PubMed
Google Scholar
Kolho, K. L., Pessia, A., Jaakkola, T., de Vos, W. M. & Velagapudi, V. Faecal and serum metabolomics in paediatric inflammatory bowel disease. J. Crohn’s Colitis 11, 321–334. https://doi.org/10.1093/ecco-jcc/jjw158 (2017).Article
Google Scholar
Murgia, A. et al. Italian cohort of patients affected by inflammatory bowel disease is characterised by variation in glycerophospholipid, free fatty acids and amino acid levels. Metab. Offic. J. Metabol. Soc. 14, 140. https://doi.org/10.1007/s11306-018-1439-4 (2018).Article
CAS
Google Scholar
Schicho, R. et al. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J. Proteome Res. 11, 3344–3357. https://doi.org/10.1021/pr300139q (2012).Article
CAS
PubMed
PubMed Central
Google Scholar
Xiao, P. et al. Mannose metabolism normalizes gut homeostasis by blocking the TNF-α-mediated proinflammatory circuit. Cell. Mol. Immunol. 20, 119–130. https://doi.org/10.1038/s41423-022-00955-1 (2023).Article
CAS
PubMed
Google Scholar
Dong, L. et al. Mannose ameliorates experimental colitis by protecting intestinal barrier integrity. Nat. Commun. 13, 4804. https://doi.org/10.1038/s41467-022-32505-8 (2022).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Guan, S. et al. UPLC-QTOF-MS-based plasma lipidomic profiling reveals biomarkers for inflammatory bowel disease diagnosis. J. Proteom. Res. 19, 600–609. https://doi.org/10.1021/acs.jproteome.9b00440 (2020).Article
CAS
Google Scholar
Sheibanie, A. F. et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23–>IL-17 axis. J. Immunol. 178, 8138–8147. https://doi.org/10.4049/jimmunol.178.12.8138 (2007).Article
CAS
PubMed
Google Scholar
Yao, C. et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nature medicine 15, 633–640. https://doi.org/10.1038/nm.1968 (2009).Article
CAS
PubMed
Google Scholar
Mrsny, R. J. et al. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc. Ntl. Acad. Sci. USA 101, 7421–7426. https://doi.org/10.1073/pnas.0400832101 (2004).Article
ADS
CAS
Google Scholar
Rohwer, N. et al. Omega-3 fatty acids protect from colitis via an Alox15-derived eicosanoid. FASEB J. Offic. Publ. Feder. Am. Soc. Exp. Biol. 35, e21491. https://doi.org/10.1096/fj.202002340RR (2021).Article
CAS
Google Scholar
Reisdorf, W. C. et al. Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease. PloS One 14, e0215033. https://doi.org/10.1371/journal.pone.0215033 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Rajakariar, R. et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Ntl. Acad. Sci. USA 104, 20979–20984. https://doi.org/10.1073/pnas.0707394104 (2007).Article
ADS
Google Scholar
Veiga-da-Cunha, M. et al. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc. Ntl. Acad. Sci. USA 116, 1241–1250. https://doi.org/10.1073/pnas.1816143116 (2019).Article
ADS
CAS
Google Scholar
Visser, G. et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: Results of the European Study on Glycogen Storage Disease type I. J. Pediatr. 137, 187–191. https://doi.org/10.1067/mpd.2000.105232 (2000).Article
CAS
PubMed
Google Scholar
Resaz, R. et al. The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb. Mol. Genet. Metab. Rep. 29, 100813. https://doi.org/10.1016/j.ymgmr.2021.100813 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Rossi, A. et al. Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: A case report. Ital. J. Pediatr. 47, 149. https://doi.org/10.1186/s13052-021-01100-w (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Huang, C. et al. Human serum metabolites as potential mediators from type 2 diabetes and obesity to COVID-19 severity and susceptibility: Evidence from Mendelian randomization study. Metabolites https://doi.org/10.3390/metabo12070598 (2022).Article
PubMed
PubMed Central
Google Scholar
Morris, S. M. Jr. Arginine metabolism: Boundaries of our knowledge. The J. Nutr. 137, 1602s–1609s. https://doi.org/10.1093/jn/137.6.1602S (2007).Article
CAS
PubMed
Google Scholar
Yoshida, Y. et al. Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis. Alimen. Pharmacol. Therap. 14(Suppl 1), 26–32. https://doi.org/10.1046/j.1365-2036.2000.014s1026.x (2000).Article
CAS
Google Scholar
Singh, K. et al. L-arginine uptake by cationic amino acid transporter 2 is essential for colonic epithelial cell restitution. Am. J. Physiol. Gastrointestin. Liver Physiol. 302, 1061–1073. https://doi.org/10.1152/ajpgi.00544.2011 (2012).Article
CAS
Google Scholar
Lee, I. A., Low, D., Kamba, A., Llado, V. & Mizoguchi, E. Oral caffeine administration ameliorates acute colitis by suppressing chitinase 3-like 1 expression in intestinal epithelial cells. J. Gastroenterol. 49, 1206–1216. https://doi.org/10.1007/s00535-013-0865-3 (2014).Article
CAS
PubMed
Google Scholar
Tanaka, K. et al. Coffee and caffeine intake reduces risk of ulcerative colitis: a case-control study in Japan. J. Gastroenterol. Hepatol. https://doi.org/10.1111/jgh.16439 (2023).Article
PubMed
Google Scholar